Hall of Fame Golfer Ernie Els Signs Endorsement Agreement with Jupiter Wellness
Multi-Year Agreement to Utilize Player's Name, Endorsement and Likeness in Connection With the Advertisement, Promotion and Sale of the Jupiter...
Year: 2020
Dr. Amir Bajoghli Published Findings on Hydroxychloroquine-induced Hyperpigmentation
MCLEAN, VA / ACCESSWIRE / November 19, 2020 / Dr. Amir Bajoghli of Skin and Laser Dermatology Center and Clinical...
GT Biopharma Announces Dr. Greg Berk, M.D. Joins Board of Directors
BEVERLY HILLS, CA / ACCESSWIRE / November 19, 2020 / GT Biopharma, Inc. (OTCQB:GTBP)(GTBP.PA) an immuno-oncology company focused on innovative...
Cannabis Suisse Corp. Announces its Decision to Work with ShipBob as a Fulfillment Center
DIETIKON, SWITZERLAND / ACCESSWIRE / November 19, 2020 / Cannabis Suisse Corp. (OTC PINK:CSUI), a fully licensed Swiss cannabis cultivation...
Strategic Vaccines, LLC Hires Lockheed Martin
COLLEGE STATION, TX / ACCESSWIRE / November 19, 2020 / Strategic Vaccines, LLC today announced that Lockheed Martin will conduct a computational...
Tarus Therapeutics Strengthens Its Board of Directors with Appointments of Mark Cohen and Robert Glassman
Industry Veterans Bring Deep Expertise and Experience to Tarus Board NEW YORK, NY / ACCESSWIRE / November 19, 2020 /...
NanoViricides Strengthens its Board of Directors with Addition of Industry Veteran Brian Zucker, CPA
SHELTON, CT / ACCESSWIRE / November 19, 2020 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a leader in developing novel...
Jushi Holdings Inc.’s Majority-Owned, Vertically Integrated Facility in Virginia Has Commenced Operations; Opens First of Six Dispensaries in Virginia and 12th BEYOND/HELLO Retail Location Nationally
BEYOND / HELLO Manassas Will Begin Medical Marijuana Dispensary Sales in the Commonwealth of Virginia on Tuesday, December 1, 2021...
Durable Responses with ADP-A2M4 in Synovial Sarcoma with Confirmed Responses in 44% of Patients and Disease Control Rate of 94% Presented at CTOS
- Data support confidence in SPEARHEAD-1 as a registrational trial - - Projected to complete recruitment of all patients in...
Neuropathix, Inc. Signs Binding Letter of Intent to Acquire Anticonvulsant – Neuroprotective Intellectual Property
DOYLESTOWN, Pa., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Neuropathix, Inc. (OTCQB: NPTX), formerly Kannalife, Inc. (the “Company” or "Neuropathix"), a...
CohBar to Present at the Piper Sandler 32nd Annual Healthcare Conference
MENLO PARK, Calif., Nov. 19, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria...
Ziopharm Oncology Presents Encouraging Clinical Data for Controlled IL-12 for the Treatment of Glioblastoma and DIPG at the 2020 Society for Neuro-Oncology Annual Meeting
– First Data from Ongoing Phase 2 Study of Controlled IL-12 in Combination with Cemiplimab Demonstrate Promising Safety Profile in...
Pure Extracts Technologies Corporate Update
VANCOUVER, British Columbia, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (“Pure Extracts” or the “Company”),...
SmileDirectClub Partners With Unified Smiles
New Partnership With Leading Dental Support Organization Increases Consumer Choice And Delivers Option To Begin SmileDirectClub Aligner Treatment At Dentists’...
Imanis Life Sciences Announces Improvements and Increased Capacity of IMMUNO-COV™, a First-in-Class Neutralizing Antibody Test for COVID-19
High-throughput clinical assay detects and quantifies SARS-CoV-2 neutralizing antibodies ROCHESTER, Minn., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Imanis Life Sciences,...
Y-mAbs Announces Update on Omburtamab in DIPG
NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical...
ChemoCentryx to Present at Two Upcoming Investor Conferences
MOUNTAIN VIEW, Calif., Nov. 19, 2020 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D.,...
Accretive Restructuring of Chalice Farms Debt Obligations Announced by Golden Leaf Holdings
Strengthens balance sheet with a 50% reduction in 2022 cash obligation and extended term on remaining balance TORONTO, Nov. 19,...
Generex signs Worldwide Licensing Deal with China Partners on the Development of an Ii-Key-H1 Swine Influenza Vaccine
$2.5 million upfront for the Ii-Key-H1 vaccine from NuGenerex-Immuno-Oncology (NGIO) and to initiate epitope identification for Ii-Key vaccine development against...
Study Utilizing Imaging Mass Cytometry Details Changes in Lung Tissue Architecture at the Single-Cell Level in Patients with COVID-19
Weill Cornell Medicine Researchers Utilize Fluidigm Hyperion Imaging System to Identify a Phenotype of Immune Cell Activity Distinct from Other...